Biometrics · 1989 · 135 citations · 4 references
Public HealthBiostatisticsClinical Data ManagementExperimental DesignHealth Data ScienceSequential ExperimentationSequential TestingStudy DesignTrial MonitoringTrial Sequential AnalysisData MonitoringInterim AnalysisSequential Clinical Trial DesignSequential Monitoring BoundariesSignificance Level
In clinical trial data monitoring, one can either introduce a discrete sequential boundary for a set of specified decision times or adopt a use function and then derive the boundary when data are monitored. If the use function approach is employed, one can adjust the frequency of data monitoring as long as the decision is not data-dependent. However, if the frequency of future data monitoring is affected by the observed data, then the probability of Type I error will no longer be preserved exactly. But the effect on the significance level and power is very small, perhaps negligible, as indicated by simulation results.
4
A Multiple Testing Procedure for Clinical Trials
Peter C. O’Brien, Thomas R. Fleming · Biometrics · 1979 · 3.3K citations
Group sequential methods in the design and analysis of clinical trials
Stuart Pocock · Biometrika · 1977 · 1.8K citations
Discrete sequential boundaries for clinical trials
K. K. Gordon Lan, David L. DeMets · Biometrika · 1983 · 1.7K citations